Recurrent UTI usually means 2 culture-confirmed symptomatic UTIs in 6 months or 3 in 12 months. This advice applies to otherwise healthy, nonpregnant women with lower-tract symptoms only.
1. Confirm the diagnosis
- Obtain a urine culture with susceptibility testing during each symptomatic episode, before antibiotics where feasible. This distinguishes reinfection, resistant bacteria, vaginal/STI causes of dysuria, and noninfectious bladder symptoms.
- Do not treat bacteria in urine when there are no symptoms, except in selected circumstances such as pregnancy or before certain urologic procedures.
- A routine CT scan or cystoscopy is usually not needed initially, but is appropriate if there is blood in urine, stones, obstruction, unusual organisms, persistent symptoms, relapsing infection, or complicated illness.
2. Treat the current symptomatic episode
Treatment should be based on the prior and current culture plus local resistance patterns. For uncomplicated cystitis, commonly used first-line options include:
- Nitrofurantoin for 5 days
- Trimethoprim-sulfamethoxazole for 3 days, only if susceptible and safe for the patient
- Fosfomycin as a single dose, where available
Avoid using fluoroquinolones such as ciprofloxacin routinely for uncomplicated cystitis when alternatives are suitable. Keep the treatment course as short as clinically appropriate, generally no more than 7 days for an acute recurrent cystitis episode. Textbook guidance supports nitrofurantoin or TMP-SMX as common empiric choices for uncomplicated cystitis, but culture-directed selection is important in recurrence. Berek & Novak's Gynecology, p. 827.
3. Prevent further episodes
Choose according to the pattern of infections and personal preferences:
- Patient-initiated treatment: keep a prescribed short antibiotic course to begin promptly when typical symptoms occur, ideally after sending a urine sample.
- Postcoital prophylaxis: a single prescribed antibiotic dose after intercourse if infections reliably follow sex.
- Continuous low-dose prophylaxis: a clinician-prescribed daily or intermittent low-dose antibiotic, commonly trialed for 6 to 12 months, with periodic review. Balance benefit against resistance, yeast infection, gastrointestinal effects, and rare drug toxicities.
- Methenamine hippurate: a non-antibiotic preventive option that can reduce recurrences for some women and is supported as an alternative to daily antibiotics in the 2025 AUA guideline. It needs clinician review, especially with kidney disease, liver disease, or interacting medicines.
- Vaginal estrogen: recommended for many peri- or postmenopausal women with recurrent UTIs and genitourinary menopause symptoms, unless contraindicated. It is local therapy, not the same as starting systemic hormone therapy.
- Hydration: increase fluids if usual intake is low. Do not routinely delay urination.
- Contraception: consider avoiding spermicides or a diaphragm if relevant, as these can raise UTI risk.
- Cranberry: may help some people, but benefit is modest and products vary widely.
- D-mannose/probiotics: current evidence is insufficient to recommend them as reliable prevention.
The main evidence-based strategies are self-start treatment, postcoital prophylaxis, continuous prophylaxis, and vaginal estrogen after menopause.
Textbook of Family Medicine, p. 280. The updated
AUA 2025 recurrent-UTI guideline also supports a patient-centered approach that includes antibiotic and non-antibiotic prevention.
Seek urgent care now if
You have fever, chills, flank/back pain, vomiting, pregnancy, severe weakness, confusion, visible blood in urine, inability to pass urine, or symptoms that are not improving within 48 hours of treatment. These can indicate kidney infection or a complicated UTI.
Pregnancy, diabetes with poor control, kidney disease, urinary catheter use, immunosuppression, known urinary tract abnormalities, or recurrent kidney infections require individualized medical assessment rather than self-treatment alone.